会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Method for measurement of tissue factor in high sensitivity and
measurement kit therefor
    • 高灵敏度组织因子测量方法及其测量套件
    • US5403716A
    • 1995-04-04
    • US924030
    • 1992-09-03
    • Kimihiko MatsuzawaRyoichi Hasegawa
    • Kimihiko MatsuzawaRyoichi Hasegawa
    • C07K16/36G01N33/86G01N33/544G01N33/535G01N33/551G01N33/577
    • C07K16/36G01N33/86G01N2333/7454Y10S435/81Y10S436/826
    • The present invention provides an improved buffer solution for conducting an immunological method for measuring apoprotein of human tissue factor, and a kit therefor. More specifically, in a method for immunologically measuring the presence or concentration of apoprotein of human tissue factor contained in a sample, which method includes the steps of (1) forming in a buffer solution a ternary complex of (a) a first monoclonal antibody which is capable of specifically binding to the apoprotein and is immobilized on a solid carrier insoluble in the buffer solution, (b) the apoprotein and (c) a labeled second monoclonal antibody which is capable of specifically binding to the apoprotein at a different site from the binding site of the first monoclonal antibody, and (2) measuring the amount of labeled second monoclonal antibody in the ternary complex to determine the presence or concentration of apoprotein in the sample, the improvement of this invention comprising employing a buffer solution(i) containing in a concentration of 2 to 15 weight % at least one nonionic surfactant having an HLB value within a range of 12 to 30, and(ii) containing a protein having a molecular weight of about 16,000 to about 50,000 and an isoelectric point of 1.0 to 5.0.
    • PCT No.PCT / JP92 / 00005 Sec。 371日期:1992年9月3日 102(e)1992年9月3日PCT PCT 1992年1月8日PCT公布。 出版物WO92 / 日本1992年7月23日。本发明提供了一种改进的缓冲溶液,用于进行用于测量人组织因子的脱蛋白的免疫学方法及其试剂盒。 更具体地,在用于免疫测定样品中包含的人组织因子的脱辅基蛋白的存在或浓度的方法中,所述方法包括以下步骤:(1)在缓冲溶液中形成(a)第一单克隆抗体的三元配合物,所述第一单克隆抗体 能够特异性结合载脂蛋白并固定在不溶于缓冲溶液的固体载体上,(b)载脂蛋白和(c)标记的第二单克隆抗体,其能够与不同部位的脱辅基蛋白特异性结合 第一单克隆抗体的结合位点,和(2)测量三元复合物中标记的第二单克隆抗体的量以确定样品中脱辅基蛋白的存在或浓度,本发明的改进包括使用缓冲溶液(i) 浓度为2至15重量%的至少一种HLB值在12至30范围内的非离子表面活性剂,和(ii)含有蛋白质 n的分子量为约16,000至约50,000,等电点为1.0至5.0。
    • 9. 发明授权
    • Process for producing substituted or unsubstituted naphthalic acids and
acid anhydrides thereof
    • 制备取代或未取代的萘二甲酸及其酸酐的方法
    • US4212813A
    • 1980-07-15
    • US950407
    • 1978-10-11
    • Ryoichi Hasegawa
    • Ryoichi Hasegawa
    • C07C51/31C07C205/57C07B3/00
    • C07C205/57C07C201/12C07C51/313C07C51/56C07D307/92
    • Process for producing substituted or unsubstituted naphthalic acids and acid anhydrides thereof by oxidation of corresponding acenaphthenes whose naphthalene nucleus may have one or two substituents from the group consisting of halogens, sulfonic acid groups, sulfonate groups, and nitro. The oxidation is performed at 30.degree.-150.degree. C. using molecular oxygen in the presence of (1) at least one heavy metal compound, such as cobalt acetate or manganese acetate, in an amount of 0.005-0.3 mole per mole of said acenaphthenes or a mixture of heavy metal compounds in that amount and a bromine compound in the range of 5.times.10.sup.-5 to 2.times.10.sup.-1 mole/liter of reaction solution as a catalyst and (2) at least one accelerator selected from the group consisting of lower fatty acid anhydrides, ketones and aldehydes, whereby side reactions such as condensation can be suppressed to a satisfactory extent, thereby leading to an improvement in yield of final product. A subsequent treatment of the oxidation product obtained by this process with peroxides, hypohalogenates, or molecular oxygen results in a higher yield.
    • 通过氧化相应的苊的方法制备取代或未取代的萘二甲酸及其酸酐,其萘核可以具有一个或两个来自卤素,磺酸基,磺酸酯基和硝基的取代基。 在(1)至少一种重金属化合物如乙酸钴或乙酸锰存在下,使用分子氧在30-150℃进行氧化,其量为每摩尔所述苊的0.005-0.3摩尔 或这种量的重金属化合物的混合物和作为催化剂的反应溶液的5×10 -5至2×10 -1摩尔/升范围内的溴化合物和(2)至少一种选自低脂肪 酸酐,酮和醛,由此可以将缩合的副反应抑制到令人满意的程度,从而导致最终产物的收率提高。 用过氧化物,次卤酸盐或分子氧随后处理通过该方法获得的氧化产物导致更高的产率。